Answers are grounded in this paper and cite their sources.
Systemic lupus erythematosus (SLE) increases cardiovascular disease (CVD) risk, and this is not explained by traditional risk factors. Characterization of blood immunologic signatures that associate with subclinical CVD and predict its progression has been challenging and may help identify subgroups at risk.
No takes yet. Share an insight, caveat, or question.
Oliveira et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: